Attention-Deficit Hyperactivity Disorder

Mahahalagang Punto

• Ang ADHD ay karaniwang neurodevelopmental disorder na may inattention, hyperactivity, impulsivity, o pinagsamang patterns.
• Nananatiling mataas ang U.S. adolescent prevalence estimates (humigit-kumulang 9.8 percent), at karaniwang mas mataas ang diagnosed rates sa males.
• Nangangailangan ng multi-source assessment ang diagnosis dahil maaaring gayahin ng anxiety, depression, sleep problems, at mga learning disorder ang mga sintomas.
• Nakaayon sa edad at severity ang treatment, na pinagsasama ang behavior interventions, school support, at medication kapag naaangkop.
• Binibigyang-diin ng nursing care ang family coaching, safety promotion, at adverse-effect monitoring.
• Ang stimulants ay Schedule II medications; dapat kasama sa RN teaching ang diversion prevention, cardiovascular warning signs, at growth monitoring.

Patopisyolohiya

Ipinapakita ng Attention Deficit Hyperactivity Disorder ang dysregulation ng attention, executive control, at inhibitory pathways na may malakas na heritable contribution. Maaaring magpatuloy ang mga sintomas hanggang adulthood at magbago ang dominant presentation sa paglipas ng panahon.

Kabilang sa functional consequences ang academics, social relationships, emotional regulation, at injury risk. Karaniwan ang comorbidity at dapat itong masuri bago pinal na buuin ang treatment plans. Maaaring manatiling hindi gaanong nakikilala ang mga sintomas hanggang later adulthood kapag ang clients ay may concern sa memory/task-completion at malakas na family-history patterns.

Sa recent U.S. youth data, inilalagay ng population estimates ang ADHD sa pinakakaraniwang diagnosed child/adolescent mental-health conditions.

Kabilang sa risk-factor patterns ang genetic loading, brain injury, early environmental toxin exposure (halimbawa lead), maternal alcohol/tobacco exposure sa pregnancy, prematurity, at low birth weight. Ang mga karaniwang maling akala (halimbawa sugar intake, screen time, o parenting style bilang nag-iisang sanhi) ay hindi suportado bilang primary etiologies.

Ang nutrition-focused interventions (halimbawa targeted elimination approaches) ay maaaring magpababa ng sintomas sa piling subgroups, ngunit halo-halo ang ebidensiya at hindi ito nagtatatag ng universal causal diet model.

Klasipikasyon

• Inattentive presentation: Mga kahirapan sa organization, follow-through, sustained attention, at working memory.
• Hyperactive-impulsive presentation: Restlessness, excessive talking, impulsive actions, at mahinang waiting tolerance.
• Combined presentation: Makabuluhang mga sintomas mula sa parehong domains.

Nursing Assessment

Pokus sa NCLEX

Gumamit ng multi-setting data (home/school/clinic) at mag-screen para sa comorbidity bago ipakahulugan ang behavior bilang ADHD lamang.

• Suriin ang symptom pattern, duration, severity, at epekto sa school, home, at peer settings.
• Direktang suriin ang mga halimbawa ng inattention at hyperactivity-impulsivity behaviors (halimbawa careless mistakes, poor task follow-through, distractibility, fidgeting, excessive talking, blurting, at interruption).
• Suriin para sa mga learning disorder, anxiety, depression, sleep problems, at conduct symptoms.
• Isama ang medical, hearing, at vision review sa diagnostic-rule-out workflows dahil walang iisang ADHD test na definitive.
• Suriin ang injury history, risk-taking, at family stress na kaugnay ng behavior burden.
• Suriin ang growth, appetite, sleep, cardiovascular baseline, at substance-use risk bago ang stimulants.
• Suriin ang kasalukuyang school supports at kapasidad ng caregivers para sa routine-based interventions.

Nursing Interventions

• Turuan ang caregivers ng structured routines, reduced-distraction study spaces, at malinaw na stepwise instructions.
• Palakasin ang positive-behavior systems gaya ng papuri, goals, at simpleng visual trackers.
• Para sa preschool-aged children (humigit-kumulang 4-5 years), unahin ang parent training na may behavioral management bago ang medication maliban kung nangangailangan ang severity ng mas maagang pharmacologic escalation.
• Makipag-coordinate sa schools para sa behavior plans, accommodations, at consistent expectations.
• Hikayatin ang educational assessment para sa IEP o Section 504 support kapag tuloy-tuloy ang classroom-function barriers.
• Palakasin ang classroom behavioral management tools (halimbawa reward systems at daily report cards) at organizational training para sa time management, planning, at school-material tracking.
• Itaguyod ang healthy sleep, physical activity, at nutrition routines.
• Suportahan ang parent training at age-appropriate self-management skill development.
• Magbigay ng referrals para sa caregiver/client sa ADHD support resources (local at online groups) upang mapabuti ang continuity at mabawasan ang caregiver isolation.
• Mag-alok ng praktikal na resource navigation (halimbawa CHADD/NRC-style education lines, specialty child-psychiatry directories, at SAMHSA locator pathways).

Panganib ng Misuse at Kaligtasan

Ang stimulant medications ay controlled substances at nangangailangan ng tuloy-tuloy na monitoring para sa diversion, misuse, at adverse effects.

Pharmacology

Kadalasang kabilang sa first-line options ang stimulants gaya ng methylphenidate o amphetamine formulations, na may maingat na pretreatment assessment at follow-up. Kabilang sa alternatives ang atomoxetine at alpha-2 agonists kapag may stimulant risks o intolerance.

Mino-monitor ng mga nars ang appetite, sleep, blood pressure, heart rate, mood change, paglitaw ng tic, at suicidal ideation risk kapag naaangkop.

Hinaharang ng stimulants ang norepinephrine at dopamine reuptake at maaaring mapabuti ang attention sa kabila ng paradoxical calming effect sa ADHD. Contraindicated ang mga ito sa MAOIs at sa loob ng 14 na araw matapos itigil ang MAOI.

Kung hindi epektibo ang isang stimulant, maraming clients ang nakikinabang sa pagsubok ng ibang stimulant formulation bago tuluyang lumipat sa nonstimulant therapy.

Kabilang sa common nonstimulant pathways ang atomoxetine at viloxazine (norepinephrine reuptake inhibition) at alpha-2 agonists gaya ng guanfacine o clonidine kapag hindi natitiis ang stimulant adverse effects.

Kabilang sa RN safety priorities para sa stimulant therapy ang:

• Mag-screen para sa misuse/diversion risk sa clients at household members bago at habang ginagamot.
• Ituro ang locked storage, no sharing ng medication, at community take-back disposal para sa unused doses.
• I-monitor ang children para sa appetite suppression, weight loss, at pagbagal ng growth trajectory.
• I-track ang common dose-related adverse effects (insomnia, decreased appetite/weight loss, abdominal pain, headache) at mas hindi karaniwang tics o blunted affect.
• Agad na i-escalate kapag may chest pain, syncope, severe hypertension symptoms, mania/psychosis, o priapism.
• Kung paradoxically lumala ang sintomas o lumitaw ang severe adverse effects, agad na i-notify ang prescriber para sa review ng dose reduction/discontinuation.
• Payuhan ang clients na iwasan ang alcohol kasama ng extended-release stimulant products.
• Palakasin na ang dose/frequency optimization ay maaaring tumagal ng 1-3 buwan at madalas nangangailangan ng lingguhang follow-up sa symptoms/adverse effects sa early titration.

Kabilang sa high-priority contraindication/caution review bago simulan ang stimulant ang glaucoma, hyperthyroidism, significant cardiovascular disease o structural defect, personal/family tic o Tourette patterns, substance-use history, at severe psychiatric instability.

Ang atomoxetine at viloxazine ay nangangailangan ng aktibong monitoring ng suicidal thoughts sa panahon ng initiation at dose changes.

Clinical Judgment Application

Clinical Scenario

Isang school-age child ang may persistent inattention, impulsive classroom disruptions, bumababang grades, at family conflict sa kabila ng tutoring.

• Recognize Cues: Multi-setting symptoms na may malinaw na functional impairment.
• Analyze Cues: Malamang ang ADHD, ngunit kailangan pa rin ang comorbidity screening.
• Prioritize Hypotheses: Prayoridad ang safety, educational support, at alignment ng family behavior plan.
• Generate Solutions: Pagsamahin ang behavior therapy, school collaboration, at medication evaluation.
• Take Action: Ipatupad ang family coaching at simulan ang prescriber follow-up protocol.
• Evaluate Outcomes: Mas mahusay na classroom engagement, nabawasang conflict, at mas kaunting risk behaviors.

Mga Kaugnay na Konsepto

• mga communication disorder - Maaaring magpalala sa school difficulties ang communication barriers.
• autism spectrum disorder - Karaniwan ang differential at comorbidity considerations.
• conduct, oppositional, at disruptive mood disorders - Nangangailangan ng maingat na assessment ang overlap ng behavioral dysregulation.
• mga anxiety-related disorder - Maaaring gayahin o palalain ng anxiety ang inattentive symptoms.
• nursing assessment at care plans - Pinapahusay ng structured assessment ang diagnostic accuracy.